Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

US Multiple Sclerosis Market and Competitive Landscape 2018 -

Research and Markets
Posted on: 02 Nov 18

The "US Multiple Sclerosis Market and Competitive Landscape - 2018" report has been added to's offering.

US Multiple Sclerosis Market and Competitive Landscape - 2018, provides comprehensive insights into Multiple Sclerosis pipeline, epidemiology, market valuations, product sales, market forecast, product forecasts, and market shares. This study accurately estimates and forecast Multiple Sclerosis market size and drug sales. This research also provides insights into Multiple Sclerosis epidemiology and late stage pipeline.

The research is classified into following sections - Multiple Sclerosis overview with definitions, symptoms, etiology, diagnosis, treatment options; Multiple Sclerosis pipeline insights covering late stage clinical trials pipeline; Multiple Sclerosis prevalence trends by countries; Multiple Sclerosis market size and forecast by countries, market events, trends; product sales and forecast by countries; market shares by countries. The research scope includes the market - USA.

Research Scope:

  • Multiple Sclerosis pipeline: Find out the drugs in clinical trials for Multiple Sclerosis by stages, phase 3 clinical trials, phase 2 clinical trials, and phase 1 clinical trials, by pharmacological class, by company
  • Multiple Sclerosis epidemiology: Find out the prevalence of Multiple Sclerosis in US; prevalence forecast to 2023
  • Multiple Sclerosis products: Identify key products marketed and prescribed for Multiple Sclerosis by brand name, by molecule, by company, by branded / generic, in US
  • Multiple Sclerosis market size: Find out the market size for Multiple Sclerosis drugs in US; find out how the market advanced from 2014
  • Multiple Sclerosis drug sales: Find out the sales of Multiple Sclerosis drugs in US
  • Multiple Sclerosis drugs sales forecast: Sales forecast for Multiple Sclerosis drugs to 2023 in US
  • Multiple Sclerosis market share analysis: Find out the market shares of Multiple Sclerosis drugs and outlook in US

For more information about this report visit

View source version on

Business Wire

Last updated on: 02/11/2018

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.